Simon Fu

Evolution of Castration-Resistant Prostate Cancer in ctDNA during Sequential Androgen Receptor Pathway Inhibition

Matti Annala, Sinja Taavitsainen, Daniel Khalaf et al. · Clinical Cancer Research · 2021 · 94 citations · Full text

Medicine, Molecular Biology, Oncology +17

Activating AKT1 and PIK3CA Mutations in Metastatic Castration-Resistant Prostate Cancer

Cameron Herberts, Andrew J. Murtha, Simon Fu et al. · European Urology · 2020 · 90 citations

Medicine, Oncology, Urology +14

<i>BRCA2</i> , <i>ATM</i> , and <i>CDK12</i> Defects Differentially Shape Prostate Tumor Driver Genomics and Clinical Aggression

Evan W. Warner, Cameron Herberts, Simon Fu et al. · Clinical Cancer Research · 2021 · 87 citations · Full text

Life Sciences, Genetics, Oncology +17

Cabazitaxel versus abiraterone or enzalutamide in poor prognosis metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase II trial

Matti Annala, Simon Fu, Jack V. W. Bacon et al. · Annals of Oncology · 2021 · 71 citations

Medicine, Oncology, Pharmacology +14

Checkpoint inhibitors in patients with metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium

Steven Yip, J. Connor Wells, Raphael Brandão Moreira et al. · Cancer · 2018 · 66 citations · Full text

Medicine, Oncology, Pharmacotherapy +17